Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Solara Active Pharma Sciences

Sector: Healthcare | Industry: Drugs & Pharma
R 413.70 2.35  | 0.57% 39.76% 12.75 1,064.35
NSE Price: Oct 22, 10:54 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 10:54 413.70 2.35 0.57% 412.05 411.35 3,424 409.00 - 415.05
BSE Oct 22, 11:03 414.70 5.25 1.28% 414.00 409.45 295 408.50 - 414.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 49,686 P/B: 1.22 NSE Code: SOLARA
52-Week Range: R 256.00 - 489.95 Dividend Yield: 1.21% BSE Code: 541540
TTM EPS: R 32.38 Book Value: R 339.87 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Solara Active Pharma Sciences 32.61 -6.20 1.39 34.01 - - -
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of NSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 151.35 - -
Net Profit 17,533.53 - -
EPS 15,015.77 - -
Book Value 6.45 - -
Average
Operating Margin 15.85 - -
Net Margin 4.18 - -
Return on Networth 7.37 - -
Return on Investment 9.70 - -
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -14.31 9.04 -14.31
Operating Profit -4.55 46.07 -4.55
Net Profit 1.15 931.13 1.15
EPS 0.74 891.75 0.74
TTM
Revenue 1.97 - 1.97
Operating Profit 9.20 - 9.20
Net Profit 40.27 - 40.27
EPS 39.10 - 39.10
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Solara Active Pharma Sciences 1,064.35 1,414.04 83.35 5.90 7.37 1.22 12.75
Astrazeneca Pharma India 5,825.00 771.42 69.56 8.84 20.03 18.19 83.74
Eris Lifesciences 5,775.83 1,005.70 303.64 29.29 28.96 4.68 19.03
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 27, 2019 NIRMAL P BHOGILAL on behalf of Shekama Family Trust  Buy Market 400 446.45 1.79
Jun 27, 2019 Pooja Srisrimal  Buy Market 820 446.45 3.66
Jun 26, 2019 NIRMAL P BHOGILAL on behalf of Shekama Family Trust  Buy Market 5,100 446.55 22.77
Jun 26, 2019 Pooja Srisrimal  Buy Market 1,500 446.55 6.70
Jun 21, 2019 NIRMAL P BHOGILAL on behalf of Shekama Family Trust  Buy Market 1,500 442.05 6.63
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
SBI Mutual Fund 4.728 5.208 5.209 5.440 5.830
Kotak Mahindra Mutual Fund 0.606 0.436 0.597 0.299 0.299
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Solara Active Pharma Sciences Ltd.

Address: 201, Devavrata, Sector 17, Vashi, Navi Mumbai, Maharashtra - 400703 | Phone: 022 2789 2924 | Fax: 022 2789 2942

Email: [email protected]

Website: www.solara.co.in

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
2.23
Piotroski F-Score
8
Modified C-Score
1
1-Year Price to Earnings
12.65
1-Year Price to Book
1.20
Earnings Yield
EBIT / Enterprise value
11.06%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,377.45 +4.35%
Caplin Point Laboratories R391.80 -1.27%
Eris Lifesciences R420.05 -0.60%
FDC R160.30 -0.37%
JB Chemicals & Pharma R363.65 -0.79%
Laurus Labs R329.00 +4.05%
Strides Pharma Science R349.00 -1.37%
Sun Pharma Adv. Research R132.30 -0.15%
Suven Life Sciences R283.85 +1.18%
Wockhardt R275.30 +3.32%
As on Oct 22, 10:54